Read + Share
Amedeo Smart
Independent Medical Education
Lipton RB, Cohen JM, Galic M, Seminerio MJ, et al. Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study. Headache 2021;61:662-672.PMID: 33891348
Email
LinkedIn
Facebook
Twitter
Privacy Policy